Amneal Pharmaceuticals (STU:2DT) Accounts Payable : €161 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Amneal Pharmaceuticals Accounts Payable?

Amneal Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2024 was €161 Mil.

Amneal Pharmaceuticals's quarterly Accounts Payable declined from Sep. 2023 (€166 Mil) to Dec. 2023 (€132 Mil) but then increased from Dec. 2023 (€132 Mil) to Mar. 2024 (€161 Mil).

Amneal Pharmaceuticals's annual Accounts Payable increased from Dec. 2021 (€116 Mil) to Dec. 2022 (€157 Mil) but then declined from Dec. 2022 (€157 Mil) to Dec. 2023 (€132 Mil).

Amneal Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Amneal Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amneal Pharmaceuticals Accounts Payable Chart

Amneal Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

92.72

125.88

116.01

156.69

131.66

Amneal Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															436.57	128.78	166.22	131.66	161.30

Amneal Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Amneal Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Amneal Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Amneal Pharmaceuticals (STU:2DT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amneal Pharmaceuticals Inc (STU:2DT) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

AMRX:USA 2DT:Germany

Address

400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, USA, 08807

Website

https://www.amneal.com

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.

Amneal Pharmaceuticals (STU:2DT) Headlines

No Headlines